Gilead Sciences, Inc.

Healthcare

NASDAQ:GILD · NASDAQ Global Select

Market Cap $155.37B Beta 0.33 P/E (TTM) 16.9

$125.14 -0.58%

-$0.73 today

52W Low $104.46High $157.29

Vol 2.66M · Avg 6.62M

EPS (TTM)$7.42

Div Yield2.55%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+14.79%

Period High

$154.92

Period Low

$103.91

Latest

$125.28

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Merck & Co., Inc.

NYSE:MRK

$296.05B

Novo Nordisk A/S

NYSE:NVO

$196.75B

Amgen Inc.

NASDAQ:AMGN

$190.71B

Pfizer Inc.

NYSE:PFE

$149.18B

Danaher Corporation

NYSE:DHR

$127.48B

Stryker Corporation

NYSE:SYK

$120.34B

Bristol-Myers Squibb Company

NYSE:BMY

$116.57B

GSK plc

NYSE:GSK

$106.57B

Sanofi

NASDAQ:SNY

$106.47B

Boston Scientific Corporation

NYSE:BSX

$69.91B

What is the latest GILD filing?

The latest filing shown is 4 dated Jun 11, 2026.

How many recent filings does GILD have?

Intrinsic Alpha currently shows 20 recent filings for GILD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.